OR56A1
gene geneOn this page
Summary
OR56A1 (olfactory receptor family 56 subfamily A member 1, HGNC:14781) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 56A1 (Q8NGH5). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 120796 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_001388488
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14781 |
| Approved symbol | OR56A1 |
| Name | olfactory receptor family 56 subfamily A member 1 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000180934 |
| Ensembl biotype | protein_coding |
| Entrez | 120796 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000641423, ENST00000641900, ENST00000641938
RefSeq mRNA: 2 — MANE Select: NM_001388488
NM_001001917, NM_001388488
CCDS: CCDS31405
Canonical transcript exons
ENST00000641900 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003813806 | 6030702 | 6030758 |
| ENSE00003814246 | 6019336 | 6027726 |
Expression profiles
Bgee: expression breadth tissue_specific, 2 present calls, max score 50.78.
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 50.78 | gold quality |
| bone marrow cell | CL:0002092 | 44.86 | gold quality |
| granulocyte | CL:0000094 | 40.28 | gold quality |
| sural nerve | UBERON:0015488 | 39.93 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 38.43 | gold quality |
| bone marrow | UBERON:0002371 | 38.31 | gold quality |
| monocyte | CL:0000576 | 36.55 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| leukocyte | CL:0000738 | 36.43 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.04 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| calcaneal tendon | UBERON:0003701 | 35.46 | gold quality |
| muscle tissue | UBERON:0002385 | 33.01 | gold quality |
| adrenal tissue | UBERON:0018303 | 32.76 | gold quality |
| liver | UBERON:0002107 | 32.63 | gold quality |
| blood | UBERON:0000178 | 32.22 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 31.98 | gold quality |
| testis | UBERON:0000473 | 30.44 | silver quality |
| prefrontal cortex | UBERON:0000451 | 29.94 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| endometrium | UBERON:0001295 | 29.45 | gold quality |
| corpus callosum | UBERON:0002336 | 29.40 | gold quality |
| urinary bladder | UBERON:0001255 | 29.27 | gold quality |
| left testis | UBERON:0004533 | 28.30 | silver quality |
| right uterine tube | UBERON:0001302 | 28.25 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| islet of Langerhans | UBERON:0000006 | 27.94 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.74 | gold quality |
| kidney | UBERON:0002113 | 27.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.23 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | adra1ab | ENSDARG00000027638 |
| danio_rerio | adra2db | ENSDARG00000054667 |
| danio_rerio | adra2da | ENSDARG00000091277 |
| caenorhabditis_elegans | ser-5 | WBGENE00008890 |
Paralogs (18): ADRB1 (ENSG00000043591), ADRA1A (ENSG00000120907), DRD2 (ENSG00000149295), ADRA2A (ENSG00000150594), GPR101 (ENSG00000165370), ADRB2 (ENSG00000169252), ADRA1B (ENSG00000170214), ADRA1D (ENSG00000171873), OR5T3 (ENSG00000172489), OR5T1 (ENSG00000181698), OR5T2 (ENSG00000181718), OR56A4 (ENSG00000183389), ADRA2C (ENSG00000184160), OR56A3 (ENSG00000184478), OR13F1 (ENSG00000186881), OR56A5 (ENSG00000188691), ADRB3 (ENSG00000188778), ADRA2B (ENSG00000274286)
Protein
Protein identifiers
Olfactory receptor 56A1 — Q8NGH5 (reviewed: Q8NGH5)
Alternative names: Olfactory receptor OR11-75
All UniProt accessions (1): A0A286YFC4
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (2): NP_001001917, NP_001375417* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (21 total): topological domain 8, transmembrane region 7, glycosylation site 3, chain 1, disulfide bond 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGH5-F1 | 84.81 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 104–196
Glycosylation sites (3): 10, 188, 198
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 19 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_RESPONSE_TO_LIPID, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION
GO Biological Process (6): cellular response to lipid (GO:0071396), system process (GO:0003008), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), signaling receptor activity (GO:0038023)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| response to lipid | 1 |
| cellular response to chemical stimulus | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| molecular transducer activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
242 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR56A1 | CNGA4 | Q8IV77 | 434 |
| OR56A1 | GPR171 | O14626 | 390 |
| OR56A1 | GPR87 | Q9BY21 | 381 |
| OR56A1 | TRIM68 | Q6AZZ1 | 338 |
| OR56A1 | PPP2R5D | Q14738 | 287 |
| OR56A1 | P2RY13 | Q9BPV8 | 266 |
| OR56A1 | PPP2R5A | Q15172 | 263 |
| OR56A1 | TRIM34 | Q9BYJ4 | 259 |
| OR56A1 | P2RY14 | Q15391 | 253 |
| OR56A1 | CNST | Q6PJW8 | 247 |
| OR56A1 | SURF2 | Q15527 | 245 |
| OR56A1 | SPNS3 | Q6ZMD2 | 243 |
| OR56A1 | FAM177A1 | Q8N128 | 241 |
| OR56A1 | TMCO5A | Q8N6Q1 | 241 |
| OR56A1 | PPP2R2A | P50409 | 237 |
IntAct
0 interactions, top by confidence:
BioGRID (2): SEPT1 (Cross-Linking-MS (XL-MS)), TRIM45 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A3B3IT45, A6NMU1, A6NND4, O88628, P0C7T3, Q6W049, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGJ4, Q8NGJ8, Q8NGJ9, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK6, Q8NGU1, Q8NGW6, Q8NGY3, Q8NH53, Q8NH54, Q8NH55, Q8NH56, Q8NH57, Q8NH60, Q8NH61, Q8NH63, Q8NH67, Q8NH76, Q8TCB6, Q8VBV9
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
209 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:6027114:A:AC | donor_gain | 0.9300 |
| 11:6026924:TGGTG:T | acceptor_gain | 0.7700 |
| 11:6026929:C:CC | acceptor_gain | 0.7500 |
| 11:6027412:G:GT | donor_gain | 0.7500 |
| 11:6027292:C:CT | donor_gain | 0.7100 |
| 11:6027441:G:T | donor_gain | 0.7000 |
| 11:6026927:TG:T | acceptor_gain | 0.6800 |
| 11:6027019:A:AC | donor_gain | 0.5900 |
| 11:6027253:G:C | donor_gain | 0.5900 |
| 11:6026925:GGTG:G | acceptor_gain | 0.5600 |
| 11:6027237:CACAA:C | donor_gain | 0.5500 |
| 11:6026926:GTG:G | acceptor_gain | 0.5400 |
| 11:6027287:G:C | donor_gain | 0.5400 |
| 11:6027231:C:A | donor_gain | 0.5300 |
| 11:6027353:C:CA | donor_gain | 0.5300 |
| 11:6027420:ATCAT:A | donor_loss | 0.5100 |
| 11:6027421:TCATA:T | donor_loss | 0.5100 |
| 11:6027422:CATAC:C | donor_loss | 0.5100 |
| 11:6027423:AT:A | donor_loss | 0.5100 |
| 11:6027424:TA:T | donor_loss | 0.5100 |
| 11:6027425:A:C | donor_loss | 0.5100 |
| 11:6027426:C:CA | donor_loss | 0.5100 |
| 11:6027013:G:C | donor_gain | 0.4900 |
| 11:6027115:T:C | donor_gain | 0.4900 |
| 11:6027427:C:T | donor_loss | 0.4900 |
| 11:6027020:G:C | donor_gain | 0.4800 |
| 11:6027236:C:CT | donor_gain | 0.4700 |
| 11:6026926:G:C | acceptor_gain | 0.4600 |
| 11:6027238:A:T | donor_gain | 0.4600 |
| 11:6027059:AGC:A | donor_gain | 0.4500 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000028919 (11:6029312 G>T), RS1000056703 (11:6029678 C>T), RS1000308790 (11:6023738 C>T), RS1000376731 (11:6025123 T>C), RS1000723946 (11:6031529 G>A), RS1000898091 (11:6025255 A>G), RS1001030860 (11:6031016 G>A,T), RS1001144075 (11:6021209 G>A), RS1001238625 (11:6025010 G>C), RS1001370110 (11:6023853 A>G), RS1001487251 (11:6029750 C>T), RS1001546065 (11:6030144 A>T), RS1001800200 (11:6024134 G>C), RS1001874121 (11:6032499 C>A), RS1001988851 (11:6032926 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.